FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to (aza)indole derivatives of formula
wherein the values T, X1-X3, R1, Q, Y, J are presented in clause 1 of the patent claim.
EFFECT: compounds possess xanthine oxidase inhibitory action that enables using it in a pharmaceutical composition for treating a disease specified in a group consisting of hyperuricemia, gouty tophus, gouty arthritis, renal diseases associated with hyperuricemia and nephrolithiasis.
19 cl, 62 tbl, 332 ex
Title | Year | Author | Number |
---|---|---|---|
5-MEMBERED HETEROCYCLIC COMPOUND AND ITS APPLICATION FOR MEDICINAL PURPOSES | 2008 |
|
RU2515968C2 |
CONDENSED HETEROCYCLIC DERIVATIVE, THERAPEUTIC COMPOSITION WHICH CONTAINS IT AND ITS APPLICATION IN MEDICINE | 2006 |
|
RU2418803C2 |
QUINOLONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2490259C2 |
N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REUPTAKE INHIBITORS | 2006 |
|
RU2574406C2 |
NOVEL INDOLINE COMPOUND AND ITS USING IN MEDICINE | 2003 |
|
RU2318808C2 |
AMINODIHYDROTHIAZINE DERIVATIVES SUBSTITUTED BY CYCLIC GROUP | 2008 |
|
RU2476430C2 |
NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
COMPOUNDS OF 3-SUBSTITUTED 1-ARYLINDOLE AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1994 |
|
RU2139287C1 |
Authors
Dates
2013-03-10—Published
2008-04-10—Filed